FM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease | International journal of molecular sciences |  | 2022 | 158 | 175 | ||
| Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells | Cells | | 2022 | 173 | 170 | ||
| NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis | International journal of molecular sciences | | 2021 | 190 | 137 | ||
| A genetic polymorphism in the pannexin1 gene predisposes for the development of endothelial dysfunction with increasing BMI | Biomolecules | | 2020 | 414 | 143 | ||
| Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression | Scientific Reports | | 2020 | 187 | 157 | ||
| Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis |  | 2020 | 207 | 0 | ||
| HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3 | PLOS ONE | | 2019 | 254 | 152 | ||
| Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patients | Journal of Infection | | 2018 | 513 | 1 | ||
| Serum cardiovascular risk biomarkers in pre-pubertal obese children | European Journal of Clinical Investigation | | 2018 | 281 | 344 | ||
| Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms | Frontiers in Immunology | | 2017 | 432 | 200 | ||
| Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population | Arteriosclerosis, Thrombosis, and Vascular Biology | | 2017 | 434 | 0 | ||
| Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function | International Journal of Cardiology | | 2017 | 481 | 0 | ||
| 4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viability | Magnetic Resonance Imaging | | 2017 | 530 | 2 | ||
| The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation | International journal of cardiology | | 2016 | 549 | 0 | ||
| Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | 2016 | 519 | 0 | |||
| Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments | European heart journal | | 2016 | 594 | 3 | ||
| Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | | 2016 | 553 | 1 | ||
| Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study | Thrombosis and haemostasis | | 2016 | 523 | 7 | ||
| Prognostic value of PCSK9 levels in patients with acute coronary syndromes | European heart journal | | 2016 | 595 | 2 | ||
| Protective role of necrostatin-1 in acute myocardial infarction | European journal of clinical investigation | | 2016 | 473 | 2 | ||
| Role of Neutrophils in Atherogenesis: an Update | European journal of clinical investigation | | 2016 | 484 | 2 | ||
| Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | | 2016 | 693 | 1 | ||
| Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43 | Cardiovascular research | | 2016 | 647 | 6 | ||
| Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | | 2016 | 583 | 6 | ||
| Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | | 2016 | 702 | 546 | ||
| Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | | 2016 | 454 | 177 | ||
| Potential useful prognostic parameters after transcatheter aortic valve implantation: editorial | European journal of clinical investigation | | 2016 | 454 | 1 | ||
| Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 | Antioxidants & redox signaling | | 2015 | 563 | 0 | ||
| Emerging pathophysiological relevance for neutrophils in acute coronary syndromes | European journal of clinical investigation | | 2015 | 427 | 0 | ||
| The role of adipocytokines in atherogenesis and atheroprogression | Current drug targets | 2015 | 498 | 0 | |||
| Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction | European journal of clinical investigation | | 2015 | 596 | 3 | ||
| Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis | European journal of clinical investigation | | 2015 | 490 | 0 | ||
| Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population | European journal of clinical investigation | | 2015 | 628 | 0 | ||
| Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury | PloS one | | 2015 | 602 | 229 | ||
| Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | | 2015 | 540 | 1 | ||
| Inflammation in arterial diseases | IUBMB life | | 2015 | 454 | 0 | ||
| Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice | Vascular pharmacology | | 2015 | 516 | 1 | ||
| Clinical relevance of adverse intracerebral artery remodeling in patients with HIV | Neurology | | 2015 | 415 | 0 | ||
| Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | | 2015 | 591 | 0 | ||
| Update on strategies limiting iatrogenic hypoglycemia | Endocrine connections | | 2015 | 419 | 165 | ||
| Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | | 2015 | 623 | 2 | ||
| Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | | 2015 | 693 | 0 | ||
| Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15 | Journal of diabetes research |  | 2015 | 496 | 0 | ||
| Editorial: update on inflammatory targets modulating atherogenesis | Current drug targets | | 2015 | 441 | 0 | ||
| Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo study | European journal of anaesthesiology | | 2015 | 512 | 0 | ||
| Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | | 2015 | 798 | 4 | ||
| Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective study | European journal of clinical investigation | | 2015 | 572 | 0 | ||
| CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes | Endocrinology | | 2015 | 608 | 1 | ||
| Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions | Handbook of experimental pharmacology | | 2015 | 613 | 0 | ||
| Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | | 2015 | 743 | 0 | ||
| Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury | The journal of sexual medicine | | 2015 | 556 | 0 | ||
| Update on the role of neutrophils in atherosclerotic plaque vulnerability | Current drug targets | 2015 | 456 | 0 | |||
| Evidence on the protective role of high-density lipoprotein (HDL) in HIV-infected individuals | Current vascular pharmacology | 2015 | 648 | 0 | |||
| Editorial: is ischemic stroke an inflammatory disease? | Current vascular pharmacology | | 2015 | 405 | 0 | ||
| Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | | 2015 | 571 | 0 | ||
| APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells | Clinical cancer research | | 2015 | 472 | 0 | ||
| Role of matrix metalloproteinases in animal models of ischemic stroke | Current vascular pharmacology | 2015 | 500 | 0 | |||
| Treatment with apixaban in a patient with recent chronic subdural haematoma: a case report | Schweizerische medizinische Wochenschrift | | 2015 | 482 | 199 | ||
| Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | | 2015 | 593 | 5 | ||
| Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose | Mediators of inflammation | | 2014 | 480 | 154 | ||
| Update on the efficacy of statin treatment in acute coronary syndromes | European journal of clinical investigation | | 2014 | 563 | 0 | ||
| Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | | 2014 | 620 | 0 | ||
| Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | | 2014 | 745 | 0 | ||
| Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity | The Journal of biological chemistry | | 2014 | 532 | 0 | ||
| Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes | Mediators of inflammation | | 2014 | 503 | 66 | ||
| Potential pathophysiological role for the vitamin D deficiency in essential hypertension | World journal of cardiology | | 2014 | 556 | 0 | ||
| Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients | European journal of internal medicine | | 2014 | 532 | 0 | ||
| Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways | British journal of pharmacology | | 2014 | 515 | 1 | ||
| Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques | Thrombosis and haemostasis | | 2014 | 530 | 0 | ||
| Reply to "precipitants of heart failure must be fully considered when predicting readmission" | European journal of clinical investigation | 2014 | 573 | 0 | |||
| Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice | Journal of cerebral blood flow and metabolism | | 2014 | 735 | 327 | ||
| Inferior vena cava parameters predict re-admission in ischaemic heart failure | European journal of clinical investigation | | 2014 | 565 | 0 | ||
| Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis | Thrombosis and haemostasis | | 2014 | 621 | 0 | ||
| Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis | Mediators of inflammation | | 2014 | 787 | 362 | ||
| Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases | Current medicinal chemistry | 2014 | 727 | 0 | |||
| Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity | World journal of cardiology | | 2014 | 622 | 224 | ||
| Advanced glycation end products play adverse proinflammatory activities in osteoporosis | Mediators of inflammation | | 2014 | 502 | 544 | ||
| Angiotensin II receptor antagonists in acute coronary syndromes | European journal of clinical investigation | | 2014 | 475 | 0 | ||
| Immunological aspects of atherosclerosis | Seminars in immunopathology | | 2014 | 593 | 0 | ||
| Carotid atherosclerotic plaque stenosis: the stabilizing role of statins | European journal of clinical investigation | | 2014 | 496 | 0 | ||
| Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic stroke | Thrombosis and haemostasis | | 2014 | 614 | 0 | ||
| The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome | Thrombosis and haemostasis | | 2013 | 515 | 0 | ||
| Pathophysiological role of neutrophils in acute myocardial infarction | Thrombosis and haemostasis | | 2013 | 538 | 0 | ||
| Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokines | European heart journal | | 2013 | 528 | 0 | ||
| Update on the protective molecular pathways improving pancreatic beta-cell dysfunction | Mediators of inflammation | | 2013 | 654 | 219 | ||
| Reply to "Management of left ventricular thrombosis in patients with apical aneurysm" | Schweizerische medizinische Wochenschrift | | 2013 | 406 | 0 | ||
| Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serum | Mediators of inflammation | | 2013 | 511 | 0 | ||
| Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction | Antioxidants & redox signaling | | 2013 | 727 | 759 | ||
| Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy | Thrombosis and haemostasis | | 2013 | 679 | 1 | ||
| The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer | World journal of surgical oncology | | 2013 | 441 | 217 | ||
| Role of matrix metalloproteinase-8 in atherosclerosis | Mediators of inflammation | | 2013 | 510 | 213 | ||
| Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesity | Mediators of inflammation | | 2013 | 524 | 232 | ||
| The role of the intraplaque vitamin d system in atherogenesis | Scientífica | | 2013 | 402 | 254 | ||
| Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongation | The American journal of emergency medicine | | 2013 | 479 | 0 | ||
| Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | | 2013 | 711 | 0 | ||
| What happened to a thrombus during apical ballooning syndrome: a case report | Schweizerische medizinische Wochenschrift | | 2013 | 496 | 0 | ||
| Pathophysiological role of the renin-angiotensin system on erectile dysfunction | European journal of clinical investigation | | 2013 | 496 | 460 | ||
| Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome | Mediators of inflammation | | 2013 | 514 | 195 | ||
| Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma | World journal of gastroenterology | | 2013 | 554 | 0 | ||
| An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes | Mediators of inflammation | | 2013 | 493 | 402 | ||
| Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience | Current drug targets | 2013 | 583 | 0 | |||
| Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1) | Mediators of inflammation | | 2013 | 520 | 247 | ||
| Inflammation is a key pathophysiological feature of metabolic syndrome | Mediators of inflammation | | 2013 | 489 | 186 | ||
| An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia | The journal of sexual medicine | | 2013 | 519 | 0 | ||
| Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases | Thrombosis and haemostasis | | 2013 | 467 | 0 | ||
| Autophagy in blood cancers: biological role and therapeutic implications | Haematologica | | 2013 | 477 | 0 | ||
| Update on evidence for treatment with ranolazine in stable angina | Schweizerische medizinische Wochenschrift | | 2013 | 471 | 0 | ||
| Chronic myeloid leukemia: reaching for the cure | Current cancer drug targets | | 2013 | 321 | 0 | ||
| Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice | Journal of cerebral blood flow and metabolism | | 2013 | 681 | 0 | ||
| Role of the renin-angiotensin system on abdominal aortic aneurysms | European journal of clinical investigation | | 2013 | 466 | 0 | ||
| Nicotinamide phosphoribosyltransferase as a target in inflammation- related disorders | Current topics in medicinal chemistry | 2013 | 434 | 0 | |||
| Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic mice | Clinical & developmental immunology | | 2013 | 528 | 0 | ||
| Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases | Clinical reviews in allergy & immunology | | 2013 | 616 | 3 | ||
| Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | | 2013 | 606 | 0 | ||
| The vulnerable coronary plaque: update on imaging technologies | Thrombosis and haemostasis | | 2013 | 409 | 0 | ||
| Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice | Arteriosclerosis, thrombosis, and vascular biology | | 2013 | 463 | 1 | ||
| Serum resistin and inflammatory and endothelial activation markers in obese adolescents | The Journal of pediatrics | | 2012 | 592 | 0 | ||
| Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals | Mediators of inflammation | | 2012 | 602 | 246 | ||
| Coronary Vasomotor Control in Obesity and Morbid Obesity | JACC. Cardiovascular imaging | | 2012 | 704 | 627 | ||
| Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injury | Current pharmaceutical biotechnology | | 2012 | 384 | 0 | ||
| Statins in the treatment of acute ischemic stroke | Current pharmaceutical biotechnology | | 2012 | 483 | 0 | ||
| Role of renin-angiotensin system in inflammation, immunity and aging | Current pharmaceutical design | 2012 | 486 | 0 | |||
| Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium | Current signal transduction therapy | | 2012 | 555 | 0 | ||
| Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury | European journal of clinical investigation | | 2012 | 606 | 0 | ||
| Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer | World journal of gastroenterology | | 2012 | 482 | 0 | ||
| At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction | Trends in pharmacological sciences | | 2012 | 449 | 0 | ||
| Role of cytokines and chemokines in non-alcoholic fatty liver disease | World journal of gastroenterology | | 2012 | 357 | 1 | ||
| Inhibition of the renin-angiotensin-aldosterone system: how to obtain this | Current pharmaceutical design | | 2012 | 420 | 0 | ||
| CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice | European heart journal | | 2012 | 652 | 1 | ||
| Update on the evidence of statin treatment to reduce plaque vulnerability | Drug metabolism letters | | 2012 | 544 | 0 | ||
| Statins and stent thrombosis | Schweizerische medizinische Wochenschrift | | 2012 | 443 | 0 | ||
| Update on the role of cannabinoid receptors after ischemic stroke | Mediators of inflammation | | 2012 | 479 | 1 | ||
| Elevated E-selectin and diastolic blood pressure in diabetic children | European journal of clinical investigation | | 2012 | 613 | 0 | ||
| The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | | 2012 | 672 | 0 | ||
| Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology | Expert review of cardiovascular therapy | 2012 | 555 | 0 | |||
| The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseases | Thrombosis and haemostasis | | 2012 | 409 | 0 | ||
| Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation | Circulation | | 2012 | 463 | 0 | ||
| Molecular imaging of matrix metalloproteinases in atherosclerotic plaques | Thrombosis and haemostasis | | 2012 | 454 | 0 | ||
| Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability | Thrombosis and haemostasis | | 2012 | 752 | 0 | ||
| Inflammatory cardiovascular risk biomarkers: update on novelties and limitations | Mediators of inflammation | | 2012 | 487 | 0 | ||
| Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability | European heart journal | | 2011 | 642 | 2 | ||
| Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome | American journal of physiology: endocrinology and metabolism | | 2011 | 627 | 0 | ||
| Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity | European heart journal | | 2011 | 634 | 0 | ||
| Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling | European journal of clinical investigation | | 2010 | 541 | 0 | ||
| Novel treatment strategy with direct renin inhibition against heart failure | Panminerva Medica | 2010 | 451 | 0 | |||
| New evidence for nicotinic acid treatment to reduce atherosclerosis | Expert review of cardiovascular therapy | 2010 | 985 | 0 | |||
| Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS) | Sleep & breathing | | 2010 | 568 | 346 | ||
| Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis | Arthritis and rheumatism | | 2010 | 828 | 3 | ||
| Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice | Arteriosclerosis, thrombosis, and vascular biology | | 2010 | 612 | 0 | ||
| Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke | Stroke | | 2010 | 624 | 0 | ||
| Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification | Critical pathways in cardiology | 2010 | 715 | 0 | |||
| CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion | Journal of Molecular and Cellular Cardiology | | 2009 | 743 | 0 | ||
| Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome | Diabetes, obesity & metabolism | | 2009 | 547 | 0 | ||
| Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis | Rheumatology | | 2009 | 617 | 0 | ||
| Ezetimibe/simvastatin | Expert opinion on drug safety | | 2009 | 501 | 0 | ||
| Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk | Pharmacological Reports | 2009 | 473 | 0 | |||
| HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | | 2009 | 623 | 0 | ||
| Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsin | Clinical and experimental pharmacology & physiology | | 2009 | 657 | 0 | ||
| The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies | Mediators of inflammation | | 2009 | 566 | 0 | ||
| Atherosclerosis is an inflammatory disease | Seminars in immunopathology | | 2009 | 815 | 153 | ||
| Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes | Rheumatology | | 2009 | 613 | 0 | ||
| Update on statin-mediated anti-inflammatory activities in atherosclerosis | Seminars in immunopathology | | 2009 | 484 | 338 | ||
| Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | Atherosclerosis | | 2009 | 577 | 0 | ||
| The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury | Thrombosis and haemostasis | 2009 | 536 | 0 | |||
| Statins, ACE inhibitors and ARBs in cardiovascular disease | Baillière's best practice & research. Clinical endocrinology & metabolism | | 2009 | 566 | 0 | ||
| Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways | Journal of Biomedicine and Biotechnology | | 2009 | 497 | 0 | ||
| Cannabinoid receptors in acute and chronic complications of atherosclerosis | British journal of pharmacology | | 2008 | 590 | 0 | ||
| Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability | Mediators of inflammation | | 2008 | 558 | 484 | ||
| Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways | Cellular signalling | | 2008 | 663 | 0 | ||
| C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes | Journal of leukocyte biology | | 2008 | 605 | 0 | ||
| New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor | Clinical interventions in aging | | 2008 | 559 | 194 | ||
| CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways | American journal of physiology. Heart and circulatory physiology | | 2008 | 589 | 0 |
